Related by context. All words. (Click for frequent words.) 68 Digestive Disease Week 68 Digestive Disease Week DDW 61 ACR ARHP 61 Digestive Diseases Week 59 DDW ® 59 ® DDW 59 Transcatheter Cardiovascular Therapeutics TCT 59 AACR NCI EORTC 59 ICAAC 59 SABCS 58 EuroPCR 58 UEGW 57 ARVO 56 ECTRIMS 56 ICAAC IDSA 55 ASCO Annual Meeting 55 ECCMID 55 NO# [002] 55 AASLD 55 ASBMR 55 SPIRIT IV 54 preclinical efficacy 54 Gastrointestinal Cancers Symposium 54 Cardiostim 54 AHA Scientific Sessions 54 Late Breaker 53 EASD 53 Therapeutics TCT 53 AABB Annual Meeting 53 ISPOR 53 Therapeutics TCT scientific 53 EchoCRT 53 Capsule Endoscopy 53 ASCO Breast Cancer 53 Genitourinary Cancers Symposium 53 #th Annual Interscience 53 Liver Meeting 53 multicenter trials 53 st Annual Meeting 53 Transcatheter Cardiovascular Therapeutics 53 ACC.# 52 EORTC NCI AACR 52 ASH Annual Meeting 52 Scientific Session 52 Prostate Cancer Symposium 52 ADA Scientific Sessions 52 Endovascular Therapy ISET 52 oral FTY# 52 HORIZONS AMI 52 Phase Ib study 52 ABSORB 52 ASCO GI 52 OLYMPIA registry 52 HepaSphere 52 VEITHsymposium 52 CYPHER R Sirolimus eluting 52 Phase Ib clinical 52 Scientific Sessions 51 Heart Failure Society 51 BIOCOM Investor Conference 51 EXPAREL ™ 51 Poster Discussion 51 CROI 51 HuMax EGFr 51 League Against Rheumatism 51 multicenter prospective 51 ROCKET AF 51 EASL 51 teriflunomide 51 TAXUS ATLAS 51 ASGT 51 PEGylated interferon beta 1a 51 Annual Scientific Sessions 51 CIRSE 51 AACR #st Annual Meeting 51 EACTS 51 everolimus eluting stent 51 LUMEN 51 ASCO GU 51 Endocrine Society #st 51 annual Transcatheter Cardiovascular 51 Long Lesion 51 DUROS 51 AACR San Antonio 51 Glufosfamide 51 ADVANCE PD 51 IN.PACT 51 CIMZIA ™ 50 placebo controlled Phase III 50 EVEREST II 50 RE LY 50 multicenter clinical 50 NCVH 50 Traficet EN 50 ESMO 50 Genous 50 solithromycin 50 Malignant Lymphoma 50 Symposium SABCS 50 liposome injection 50 Zenvia Phase III 50 Chemotherapy ICAAC 50 TMC# C# 50 placebo controlled clinical 50 CTRC AACR San Antonio 50 Stent Thrombosis 50 ESTRO 50 randomized controlled Phase 50 MEND CABG 50 Phase 2b study 50 AUA Annual Meeting 50 multicenter Phase 50 ASCO 50 entitled Synergistic 50 randomized controlled clinical 50 EDEMA3 50 nd Annual Meeting 50 SYNTAX trial 50 Amrubicin 50 AAPM 50 AIR2 Trial 50 Hsp# Inhibitor 50 Phase 2a clinical 50 USpella 50 Pediatric Academic Societies PAS 50 Scientific Meeting 49 Gynecologic Cancer Society 49 Society CTOS 49 ASCO abstract 49 Alzheimer Disease ICAD 49 AAGL 49 ICAD 49 #th Interscience Conference 49 Diabetic Macular Edema DME 49 Carfilzomib 49 Molecular Targets 49 CardioFit 49 ESCRS 49 Prospective Randomized 49 Phase 1b trial 49 Oral Presentations 49 ASCO Genitourinary Cancers Symposium 49 AAPS Annual Meeting 49 Hagop M. 49 phase IIIb 49 Antimicrobial Agents 49 ENDEAVOR IV 49 YONDELIS 49 drug eluting balloons 49 multicentre randomized 49 Podium Presentation 49 ThermoDox ® 49 AAN Annual Meeting 49 RTOG 49 CLL8 49 interventional vascular medicine 49 Eluting Coronary Stent System 49 recurrent GBM 49 HORIZONS AMI trial 49 Cambridge Healthtech Institute 49 BioContact Quebec 49 Guanilib 49 Lysosomal Disease Network 49 Ambrisentan 49 EORTC NCI AACR Symposium 49 ZYBRESTAT TM 49 Pediatric Academic Societies 49 prospective multicenter 49 PITTCON 49 Acute Myocardial Infarction 49 BRIM2 49 #nd EORTC NCI 49 SIR Spheres 49 PROSTASCINT R 49 Endocrine Society Annual Meeting 49 Spine Arthroplasty Society 49 randomized Phase III 49 Sipuleucel T 49 Molecular Medicine Tri 49 pharmacokinetic PK 49 relapsing multiple sclerosis 48 Biological Therapy 48 TG MV 48 PRECISE 48 CTAP# Capsules 48 depsipeptide 48 ARIKACE 48 HuMax CD4 48 multicenter phase 48 EULAR 48 TAXUS TM 48 Phase IIB 48 multicenter 48 Resolute DES 48 NSABP 48 BioPartnering Europe 48 ECNP 48 RE LY ® 48 ATL/TV# 48 TEMSO 48 Phase 2a trial 48 ADAGIO study 48 ASTRO Annual Meeting 48 BAL# [002] 48 Hematology ASH 48 Clinical Efficacy 48 Interventional Cardiologists 48 European CanCer Organisation ECCO 48 Patrick W. Serruys 48 prospective randomized multicenter 48 drug eluting stent DES 48 ASN Renal Week 48 EOquin TM 48 Clinical Trial Results 48 Vascugel ® 48 mGluR5 negative 48 LOPE C 48 pan HDAC inhibitor 48 ORMD 48 Phase III VISTA 48 VEITHsymposium ™ 48 Zarnestra 48 selective androgen receptor modulator 48 EORTC 48 Phase IIIb 48 phase Ib 48 SUPERA stent 48 Oral Fingolimod 48 bazedoxifene conjugated estrogens 48 C# BioVentures 48 hereditary deficiency 48 Annual Transcatheter Cardiovascular 48 HFSA Annual 48 Dr. Siegall 48 EuroIntervention 48 CUSTOM II 48 ISTH 48 acute PAO 48 International Myeloma Workshop 48 XIENCE TM 48 bioabsorbable stent 48 angiotensin receptor blocker ARB 48 II Clinical Trial 48 PROSTVAC TM 48 Daclizumab 48 Nutracon 48 Drug Eluting Stents 48 Endoscopic Surgeons SAGES 48 Endourology 48 InspireMD 48 RhuDex ® 48 Clinical Oncology Annual Meeting 48 RECORD1 48 dose escalation trial 48 BioPharm America 48 Tesetaxel 48 Malignant Mesothelioma 48 Orqis Medical 48 CCX# B 47 Xanafide 47 Dr. Yatscoff 47 ABSORB trial 47 CIMZIA TM 47 Natural Orifice Surgery 47 iSBTc 47 Neuromodulation Society 47 Phase 1b clinical 47 controlled multicenter Phase 47 REALITY Trial 47 randomized discontinuation trial 47 CHEST 47 multicenter Phase II 47 ENDEAVOR III 47 ONTARGET 47 Pirfenidone 47 SUCCEED trial 47 CALGB # [002] 47 Azedra 47 lexidronam injection 47 pharmacokinetic PK study 47 Castration Resistant Prostate Cancer 47 AASLD Meeting 47 Rheumatology ACR Annual 47 Safinamide 47 EINSTEIN DVT 47 Endocrine Society ENDO 47 ASTEROID 47 histone deacetylase HDAC inhibitor 47 CardioBip 47 brivaracetam 47 Initiated Phase 47 Randomized Phase 47 Ampligen ® 47 CALGB 47 ERA EDTA 47 NSTI Nanotech 47 APEX PD 47 PROMUS Element Stent 47 Deforolimus 47 Canaccord Adams Musculoskeletal 47 Preclinical Study 47 Neurology AAN 47 ToGA 47 ZYBRESTAT fosbretabulin 47 CORD II 47 telcagepant 47 Mipomersen 47 TAXUS IV 47 Eluting Stent 47 Ophthalmology ARVO 47 Elagolix 47 Teriflunomide 47 Plecanatide 47 efficacy tolerability 47 pain palliation 47 XIENCE 47 Phase IIIb clinical 47 CEQ# 47 MaxCyte 47 tolvaptan 47 Embolic Protection Device 47 proteasome inhibitor 47 Phase III randomized 47 Acute MI 47 multicentre 47 Bapineuzumab 47 Antiviral Therapy 47 Cancer iSBTc 47 OZURDEX ® 47 Phase 1b 47 Proxinium TM 47 PROactive Study 47 HIF PHI 47 Phase 2a 47 UPLYSO 47 Abstract Number 47 Factor VIIa 47 Logical Therapeutics 47 Preclinical Data 47 ATVB 47 Tanespimycin 47 APTIVUS 47 Cypher Stent 47 dose escalation Phase 47 randomized multicenter trial 47 FOLFIRI chemotherapy 47 PAINWeek 47 Prostate AdenoCarcinoma Treatment 47 Solid Tumors 47 LT NS# 47 Coherex 47 XIENCE V Everolimus Eluting 47 Breaking Clinical Trials 47 Genous stent 47 Archexin 47 BIO InvestorForum 47 fosbretabulin 47 Advanced Renal Cell 47 Endovascular Therapy 47 CCX# 47 sipuleucel T 47 Quinamed 47 Randomized Evaluation 47 SAGES 47 multicenter randomized placebo controlled 47 Gastrointestinal Cancer 46 ongoing Phase 1b 46 phase IIa clinical 46 phase 2a 46 Inhaled AAT 46 Breast Cancer Symposium 46 Hematology ASH Annual Meeting 46 Pharmacodynamics 46 AVADO 46 Opexa 46 BrachySil TM 46 Breast Cancer Symposium SABCS 46 ProLindac TM 46 ENESTnd 46 Val HeFT 46 sulodexide 46 Syllego system 46 LibiGel ® 46 multicentric 46 Cachexia 46 REG2 46 Connective Tissue Oncology 46 PERSEUS 46 antiplatelet 46 Phase III HEAT 46 SPIE Photonics West 46 Edwards SAPIEN valve 46 ECCO ESMO 46 Selective Cardiac Myosin Activator 46 beta 1a 46 MEDICA 46 edoxaban 46 PICSO ® 46 Fondaparinux 46 HQK 46 PSN# [002] 46 patients undergoing percutaneous 46 Oral Presentation 46 prospective multicenter randomized 46 FOLFOX6 chemotherapy regimen 46 darinaparsin ZIO 46 HUPO 46 Opportunistic Infections CROI 46 ProSavin 46 PharmaMedDevice 46 Inflammatory Arthritis 46 SYN# 46 Interventions SCAI 46 Carotid 46 Fibrillex TM 46 AACR EORTC NCI 46 HFSA 46 Endeavor drug eluting 46 stent DES 46 sunitinib malate 46 SupplySide East 46 RADIANT 46 TAXUS Stent 46 Valsartan 46 ASCRS 46 sorafenib tablets 46 non valvular atrial 46 oral ridaforolimus 46 Phase #b/#a clinical 46 SNM Annual Meeting 46 inhaled treprostinil 46 Paradis Vaso Shield 46 phase IIb clinical 46 Endovascular Valve Edge 46 viral kinetic 46 Neuropathic Pain 46 NCIC CTG 46 PFO migraine 46 assessing T DM1 46 AACR #nd Annual Meeting 46 tolerability profiles 46 romidepsin 46 InterGrowth 46 ISHLT 46 vascular disrupting agent 46 Interventional Radiological Society 46 SAWC 46 Biophysical Society 46 Chicago Multidisciplinary Symposium 46 Phase #/#a trial 46 Respiratory Society 46 Bortezomib 46 Endocrine Society #nd 46 ACHEMA 46 Lung Transplantation 46 MERLIN TIMI 46 Alvesco R 46 REVEAL Registry 46 Cardiovascular Horizons 46 elotuzumab 46 MyoCell 46 Cardiac Resynchronization Therapy 46 Kahalalide F 46 Pervasis 46 Zemplar Capsules 46 AACR Annual Meeting 46 CHAMPION PCI 46 PrevOnco 46 CA4P 46 Interscience Conference 46 NATRECOR ® 46 Candesartan 46 Therapeutic Targets 46 eyeforpharma 46 Phase Ib II 46 phase IIb 46 Liver EASL 46 RESOLUTE clinical 46 CRLX# 46 Combo Stent 46 Xpert HemosIL FII 46 AVAX 46 ACR ARHP Annual 46 CLARITY study 46 Clinical Oncology ASCO Annual 46 AQ4N 46 Multaq R 46 multicenter randomized double 46 mg administered orally 46 LUX Lung 46 ENDO 46 SupplySide West 46 DB# [003] 46 Dose Ranging Study 46 Edoxaban 46 MKC# MKC# PP 46 YONDELIS R 46 America HFSA 46 DU #b 46 somatostatin analogue 46 ZFP TF 46 CLEO QELS 46 novel histone deacetylase 46 evaluating REVLIMID 46 ixabepilone 46 vidofludimus 46 GASTRO 46 Clavis Pharma 46 palifosfamide 46 PFO closure 46 Planet xMAP Europe 46 CARE HF 46 BRIM3 46 Respiratory Viral Infections 46 ISC'# 46 nab paclitaxel 46 TAXUS Element Paclitaxel Eluting 46 FOLOTYN ® 46 Inflammatory Bowel Diseases 45 ularitide 45 Cardiovascular Therapeutics 45 delafloxacin 45 riociguat 45 NEUVENGE 45 LCP Tacro 45 BOLDER II 45 FOOD EXPO 45 substudy 45 tasocitinib 45 PackExpo 45 relapsed refractory multiple myeloma 45 Acute Heart Failure 45 ASMBS 45 antithrombotic therapies 45 Endurant 45 Denufosol 45 Clinical Trial Data 45 anti arrhythmic drug 45 Bazedoxifene 45 EFNS 45 DASISION 45 EADV 45 Poster Session 45 volociximab 45 Aplidin 45 neratinib 45 Harry Palmin President 45 Gabapentin GR 45 vascular disrupting agents 45 Solesta 45 paclitaxel eluting stent 45 prospective randomized 45 Hematology Annual Meeting 45 ibandronate 45 Clinical Oncology Gastrointestinal Cancers 45 Metricath 45 SPIRIT FIRST 45 Wound Healing Society 45 Net atHome ™ 45 urethral bulking agent 45 Teysuno 45 label multicenter Phase 45 abstr 45 HCV SPRINT 45 Atrial Fibrillation Symposium 45 MoxDuo 45 Ablation System 45 investigational antiplatelet 45 Phase III pivotal 45 AACR 45 RESTORE CLI 45 XL# XL# XL# 45 ThermoDox R 45 somatostatin analog 45 Addex Pharmaceuticals SWISS ADXN 45 Phase 2b 45 MT# MEDI 45 Poster Presentation 45 TheraCIM 45 SAWC WHS 45 fully bioabsorbable 45 ISTODAX ® 45 ENDEAVOR 45 Keystone Symposia 45 Hematology Meeting 45 Antiviral Activity 45 MEND CABG II 45 Vulnerable Plaque 45 varespladib 45 ACOMPLIA R 45 oral Xeloda 45 EULAR Annual 45 Hepatocellular Carcinoma HCC 45 & EXPO ITEXPO 45 Mass Spectrometry ASMS 45 LD Micro 45 MedNet Solutions 45 Haemostasis ISTH 45 drug eluting coronary stent 45 Natalizumab 45 selective antagonist 45 Mineral Research ASBMR 45 Diabetes EASD 45 ENMD # 45 BioMatrix 45 GlassBuild America 45 Diabetic Macular Edema 45 Annual ICAAC 45 Metastatic Melanoma 45 BAY #-# 45 SPIRIT III 45 ORAL Sync 45 Irinotecan 45 BioProcess International 45 XClinical 45 INSPIRE Trial Phase III 45 Proc Am Soc 45 perifosine KRX 45 EAACI 45 IASLC 45 Ceflatonin R 45 EuroMedtech 45 TLR antagonist 45 MASCC 45 Medical Oncology ESMO 45 registrational Phase 45 INCB# [001] 45 EuroMold 45 American Thoracic Society 45 Prof. Gozes 45 Experimental Biology EB 45 Ocrelizumab 45 BIOMEDevice 45 Oligonucleotide Therapeutics Society 45 IEEE GLOBECOM 45 TARGIT 45 ABCSG 45 IFN α 45 trabectedin 45 Phase IIA 45 Microplasmin 45 Well Tolerated 45 farletuzumab 45 KRN# 45 MOZOBIL 45 Platelet Inhibition 45 CAMMS# 45 velafermin 45 PreCISe 45 Dr. Gulfo 45 Dr. Dov Tamarkin 45 Pivotal Phase II 45 BR.# 45 BioMarck 45 Urocortin 2 45 POWER GEN International 45 Keynote Session 45 pharmacokinetic pharmacodynamic 45 Selective Cardiac Myosin 45 Fabry Disease 45 Sym# 45 Phase 2b kidney transplant 45 TIMI Study Group 45 AIIM Exposition 45 paclitaxel eluting stents 45 Ranolazine 45 DISKCON 45 ASNR 45 acute ischemic stroke 45 LBH# 45 GTCbio 45 Oncology ASTRO 45 Thoraxcenter Erasmus University 45 Ketotransdel 45 Phase Ib 45 OncoGel 45 TMC# [002] 45 Vandetanib 45 pharmacodynamic properties 45 Continence Society 45 paclitaxel poliglumex 45 PERSEUS clinical program 45 Daniel Von Hoff 45 Severe Sepsis 45 Lisofylline 45 AACR Meeting 45 EndoTAG TM -1 45 Phase III ALLEGRO 45 Windhover Information 45 metastatic hormone refractory 45 rFactor XIII 45 peripheral stent 45 JAK1 45 RHUCIN 44 DAVANAT 44 plerixafor 44 Mycophenolate Mofetil 44 NCCTG 44 mitogen activated ERK kinase 44 CRMD# 44 Brachytherapy Society 44 novel oral anticoagulant 44 HIMSS# Interoperability Showcase 44 Abbott bioabsorbable stent 44 orally inhaled migraine 44 randomized multicenter 44 INT# [002] 44 XIENCE V PROMUS Stent 44 Chemophase 44 DAPT 44 Pivotal Trial 44 BioContact Québec 44 pharmacokinetics PK 44 SAEM Annual Meeting 44 trodusquemine 44 PEG SN# 44 axitinib 44 Stabilimax NZ 44 Zilver PTX stent 44 SCCHN 44 Acute Ischemic Stroke 44 forodesine 44 Simulect 44 ritonavir boosted 44 Telaprevir 44 Catena ® 44 coronary stent merged 44 Hexvix 44 DNA methylation markers 44 Canaccord Adams Hepatitis C 44 transoral 44 number NCT# ClinicalTrials.gov 44 blinded randomized 44 Diabetic Foot 44 Pazopanib 44 relapsing remitting MS RRMS 44 Multiple Myeloma MM 44 eltrombopag 44 Aplidin R 44 subgroup analyzes 44 MobileFocus 44 RE COVER 44 LabAutomation# 44 Hyphanox 44 Ovarian PLCO Cancer 44 OneMedForum 44 Cancers Symposium 44 Trandolapril 44 Anavex #-# 44 Advanced Magnetics 44 HIMSS Interoperability Showcase 44 GRNCM1 44 VoiceCon San Francisco 44 EGFR HER2 44 Photocure ASA 44 Group RTOG 44 BCIRG 44 GORE TAG Device 44 ATTRACT 44 Clinical Dermatology 44 dose escalation clinical 44 www.snwusa.com 44 RCW Breast Cancer 44 PREOS R 44 Advanced Neuroendocrine Tumors 44 European CanCer Organisation 44 ERATO 44 HGS# 44 metaglidasen 44 ISSWSH 44 Xerecept 44 aerosolized KL4 surfactant 44 Vascular Annual Meeting 44 SMi 44 ERA D2C Convention 44 TAXUS Liberte 44 Lixivaptan 44 ASTMH 44 ANTEGREN 44 Neulasta ® 44 Biotech Showcase 44 Dr. Gussak 44 Liprostin 44 Orazol 44 Hernia Society 44 multicenter clinical trials 44 Romidepsin 44 Manja Bouman CEO 44 Multicenter 44 transthyretin TTR mediated amyloidosis 44 CAMPATH 44 Personalized Immunotherapy 44 paclitaxel stent 44 Controlled Release 44 multicenter randomized clinical 44 Recombumin 44 Long Term Efficacy 44 Phase III placebo controlled 44 PROTECT AF 44 SANUWAVE 44 analgesic efficacy 44 Symphogen 44 Clavis Pharma ASA 44 prospective observational 44 PKC# 44 AEEDC 44 atacicept 44 ASCO Prostate Cancer 44 Betaferon R 44 ExTRACT TIMI 44 Movement Disorder 44 pertuzumab 44 novel VDA molecule 44 multicenter randomized controlled 44 Neurological Surgeons AANS 44 Hypertension ASH 44 Biotec Pharmacon 44 RESOLUTE 44 Rivaroxaban 44 EORTC NCI 44 Targretin 44 Targeted Anticancer Therapies 44 RIBBON 44 CIPN 44 treatment naive genotype 44 MEK inhibitor 44 Celsion Corporation 44 TAXUS Liberté stent 44 Interventional Radiology SIR 44 Inc. Nasdaq OPTR 44 Annual Interscience Conference 44 Aflibercept 44 Cardiology ESC 44 CMEF 44 PARTNER Trial 44 oral rivaroxaban 44 San Antonio Breast Cancer 44 XIENCE V demonstrated 44 ASGCT 44 Boceprevir 44 PROPEL 44 Alpharadin 44 www.aiimexpo.com 44 CLARITY TIMI 44 Spine Society 44 anticancer compound 44 Nasdaq IDRA today 44 Neovasc Reducer 44 trastuzumab DM1 T DM1 44 Pharmacoeconomics 44 TASKi2 44 TXPO 44 Bucindolol 44 Ophena 44 phase IIa 44 Unither 44 StemEx 44 Inhalation Solution 44 STENT 44 AAO HNSF Annual Meeting 44 thrombus aspiration 44 & OTO EXPO 44 PXD# 44 Radiological Society 44 R roscovitine 44 Heart Failure Patients 44 Environ Health Perspect 44 MoxDuo IR 44 Thermo Scientific booth 44 Imprime PGG 44 double blinded randomized 44 immunotherapeutic vaccine 44 CIBMTR 44 randomized Phase IIb 44 Nephrology ASN Renal 44 TAXUS V 44 Arteriosclerosis Thrombosis 44 ELIQUIS 44 Phase III randomized controlled 44 OneMedPlace Finance Forum 44 ASCT 44 EDEMA3 trial 44 Cellulaze 44 verteporfin 44 obatoclax 44 immatics 44 Randomized Clinical Trial 43 AACR IASLC Joint 43 CELGENE 43 IFT Annual Meeting 43 lorcaserin Phase 43 Sybase TechWave 43 administered subcutaneously 43 GV Expo 43 Remote Sensing ASPRS 43 Antibody Engineering 43 Angiox R 43 resolvin 43 Novalis Circle 43 adult chronic ITP 43 Genome Biology 43 entinostat 43 Combination REOLYSIN R 43 Outpatient Setting 43 VEITHsymposium TM 43 PROMACTA 43 BIOTECHNICA 43 carotid artery stenting CAS 43 Randomized Double blind 43 StemEx R 43 Semafore Pharmaceuticals 43 IL# PE#QQR 43 Gemzar ® 43 Solorel TM 43 National Surgical Adjuvant 43 trial evaluating PRX# 43 Blinatumomab 43 Phase 2a Clinical Trial 43 candesartan cilexetil 43 Revotar 43 AAG geldanamycin analog 43 SU# [003] 43 Vascular Biology ATVB 43 Edge STudy 43 atrasentan 43 PROCRIT R 43 maximally tolerated dose 43 DEEP AF 43 REFLEX 43 Rheumatology Annual 43 Zilver PTX 43 ACAM 43 Dr. Grekos 43 Intervention Effectiveness 43 BrachySil ™ 43 immunomodulatory therapy 43 Nordic ACTI 43 RoboNexus 43 RENAL 43 CPhI Worldwide 43 Neurology Annual Meeting 43 aliskiren 43 Photovoltaics Summit 43 Phase 2a Study 43 GRN#L 43 registrational 43 #rd Annual CTRC 43 Phase III Psoriasis 43 AEZS 43 Imedex 43 AP# [003] 43 ACRIN 43 TQT 43 Biologic Therapy 43 LD MICRO Conference 43 Neoplasia 43 Fuel Cell Seminar 43 Therapeutics Roundtable 43 In3 WEST 43 Vernakalant 43 CYT# 43 preclinical pharmacokinetic 43 ZD# [001] 43 IRX 2 43 ESHRE 43 AFRS TM 43 Neck Cancer 43 NASDAQ CXSP announced 43 pharmacodynamic profile 43 REGiMMUNE 43 ASSH 43 Rheumatology Annual Meeting 43 Gastroenterology ACG 43 BIO# 43 Meets Primary Endpoint 43 DEB# 43 Oramed 43 BiTE antibody MT# 43 Glatiramer acetate 43 Stem Cell Research ISSCR 43 RenalGuard System TM 43 saphenous vein graft 43 Spirus Medical 43 ON #.Na 43 Pooled Analysis 43 Catheter Ablation 43 Androgen Receptor 43 randomized Phase 2b 43 BioPartnering 43 PROactive study 43 HCV NS5B polymerase 43 GW# [003] 43 SUTENT ® 43 ISPD 43 Endosense 43 clevidipine 43 Association EHA 43 Medidur TM FA 43 th Interscience Conference